Wegovy
Last Reviewed: Oct 29, 2024
Drug Details
Generic Name:
Semaglutide injection
Availability:
Prescription only
Therapeutic Class:
GLP-1 receptor agonist
Forms:
Injection solution in a prefilled single-use pen
Administration:
Subcutaneous injection
Therapeutic Uses:
- To help with chronic weight management in obese or overweight American adults and children above 12 years of age
- To lower the risk of major cardiovascular events like stroke, heart attack, and death in overweight or obese adults with blood vessel or heart disease
Controlled Status:
Not a controlled substance
Wegovy Drug Class
Wegovy (wee-go-vee) is a glucagon-like-peptide-1 (GLP-1) receptor agonist.
Wegovy Age Range
Wegovy is approved for use in:
- Adults with a body mass index (BMI) of 30 kg/m2 or higher or a BMI of 27 kg/m2 or higher and at least one of the serious health issues related to obesity, such as high blood pressure, type 2 diabetes, or high cholesterol.
- Children 12 years of age and older with a BMI at the 95th percentile or higher.
SOCIAL